Pacira BioSciences (PCRX) Acquisitions (2019 - 2026)
Pacira BioSciences (PCRX) posted quarterly Acquisitions of $335000.0 for Q1 2026, down 97.99% year-over-year from $16.7 million in Q1 2025, and down 97.99% quarter-over-quarter from $16.7 million in Q1 2025.
Pacira BioSciences (PCRX) Acquisitions (2019 - 2026) Analysis & Trends
Pacira BioSciences' Acquisitions history runs 3 years deep, the most recent figure standing at $335000.0 for Q1 2026.
- In Q1 2026, Acquisitions fell 97.99% year-over-year to $335000.0; the TTM figure through Mar 2026 stood at $335000.0 (down 97.99% YoY), while the FY2025 annual figure was $16.7 million, changed N/A from the prior year.
- Acquisitions for Q1 2026 stood at $335000.0, down from $16.7 million in the prior quarter.
- The five-year high for Acquisitions was $16.7 million in Q1 2025, with the low at $335000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.40 Bn | 43.44 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.69 Bn | 40.03 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.28 Bn | 30.60 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.01 Bn | 19.35 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.92 Bn | 18.03 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.95 Bn | 11.42 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Pacira BioSciences | 960.11 Mn | 709.08 Mn | 148.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 335,000.00 |
| Mar 31, 2025 | 16.70 Mn |
| Dec 31, 2019 | -992,000.00 |